Human GM-CSF / CSF2 Protein GMP-10015-HNAH from Sino Biological, Inc.

Product Specs
ItemHuman GM-CSF / CSF2 Protein
CompanySino Biological, Inc.
Price $348.00Supplier Page View Company Product Page
Catalog NumberGMP-10015-HNAH
Size20 µg
Conjugate/TagUnconjugated
Purity≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC
FormatSupplied as sterile PBS, pH 7.4
Activity1.Measured in a cell proliferation assay using TF-1 human erythroleukemic cells.The ED50 for this effect is typically 0.06-0.3 ng/mL. 2.Dendritic Cells (DCs) generation and maturation. CD14+ monocytes were differentiated into immature DCs by GM-CSF (Cat#GMP-10015-HNAH) and IL4 (Cat#GMP-11846-HNAE) for 6 days. DCs were matured by TNF (Cat#GMP-10602-HNAE) for 2 days.(Routinely tested) 3.Dendritic Cells (DCs) generation. CD14+ monocytes were differentiated into immature DCs by GM-CSF (Cat#GMP-10015-HNAH) and IL4 (Cat#GMP-11846-HNAE) for 6 days.(Routinely tested)
TypeRecombinant protein
Molecular WeightThe recombinant human GMCSF consists of 127 amino acids and predicts a molecular mass of 14.5 kDa. As a result of glycosylation, it migrates as an approximately 19-29 kDa band in SDS-PAGE under reducing conditions
SpeciesHuman
Molecule NameCSF2
Source/Expression SystemHEK293 Cells
NCBI Full Gene Namecolony stimulating factor 2
NCBI Gene AliasesCSF, GMCSF

37 Industrial Blvd

Suite B

Paoli, PA 19301

United States

Phone: 215-583-7898
Fax: 267-657-0217

Email: marketing@sinobiological.com

(1) An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical ModelsFrontiers in immunologyJanuary 1, 2022Chen X, Xue L, Ding X, Zhang J, Jiang L, Liu S, Hou H, Jiang B, Cheng L, Zhu Q, et al.monocytes in complete RPMI-1640 containing 100 ng/mL GM-CSF (Sino Biological Inc, China, catalog no. GMP-10015-HNAH) and 100 ng/mL IL-4 (Sino Biological Inc, China, GMP-11846-HNAE) for 6 days. Anti-TIGIT mAbs were labeled

Human GM-CSF / CSF2 Protein